nodes	percent_of_prediction	percent_of_DWPC	metapath
Dexfenfluramine—SLC6A4—chronic obstructive pulmonary disease	0.25	0.523	CbGaD
Dexfenfluramine—CYP1A2—chronic obstructive pulmonary disease	0.228	0.477	CbGaD
Dexfenfluramine—CYP2A6—Arformoterol—chronic obstructive pulmonary disease	0.069	0.144	CbGbCtD
Dexfenfluramine—CYP2A6—Formoterol—chronic obstructive pulmonary disease	0.069	0.144	CbGbCtD
Dexfenfluramine—CYP2A6—Montelukast—chronic obstructive pulmonary disease	0.0523	0.109	CbGbCtD
Dexfenfluramine—CYP2E1—Aminophylline—chronic obstructive pulmonary disease	0.0387	0.0808	CbGbCtD
Dexfenfluramine—CYP2A6—Prednisolone—chronic obstructive pulmonary disease	0.0307	0.064	CbGbCtD
Dexfenfluramine—CYP2C19—Arformoterol—chronic obstructive pulmonary disease	0.0286	0.0596	CbGbCtD
Dexfenfluramine—CYP2C19—Formoterol—chronic obstructive pulmonary disease	0.0286	0.0596	CbGbCtD
Dexfenfluramine—CYP2C9—Formoterol—chronic obstructive pulmonary disease	0.0237	0.0495	CbGbCtD
Dexfenfluramine—CYP2C9—Arformoterol—chronic obstructive pulmonary disease	0.0237	0.0495	CbGbCtD
Dexfenfluramine—CYP1A2—Aminophylline—chronic obstructive pulmonary disease	0.0224	0.0467	CbGbCtD
Dexfenfluramine—CYP2D6—Arformoterol—chronic obstructive pulmonary disease	0.0217	0.0453	CbGbCtD
Dexfenfluramine—CYP2D6—Formoterol—chronic obstructive pulmonary disease	0.0217	0.0453	CbGbCtD
Dexfenfluramine—CYP2D6—Tiotropium—chronic obstructive pulmonary disease	0.0194	0.0404	CbGbCtD
Dexfenfluramine—CYP2C9—Montelukast—chronic obstructive pulmonary disease	0.018	0.0375	CbGbCtD
Dexfenfluramine—CYP2C19—Prednisone—chronic obstructive pulmonary disease	0.012	0.025	CbGbCtD
Dexfenfluramine—Cinacalcet—CYP1A2—chronic obstructive pulmonary disease	0.000986	0.686	CrCbGaD
Dexfenfluramine—Methamphetamine—SLC6A4—chronic obstructive pulmonary disease	0.000451	0.314	CrCbGaD
Dexfenfluramine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—chronic obstructive pulmonary disease	6.16e-05	0.00152	CbGpPWpGaD
Dexfenfluramine—HTR2C—G alpha (q) signalling events—HTR2A—chronic obstructive pulmonary disease	6.03e-05	0.00149	CbGpPWpGaD
Dexfenfluramine—SLC6A4—Circadian rythm related genes—SERPINE1—chronic obstructive pulmonary disease	5.99e-05	0.00148	CbGpPWpGaD
Dexfenfluramine—HTR2C—GPCRs, Class A Rhodopsin-like—ADRB2—chronic obstructive pulmonary disease	5.96e-05	0.00147	CbGpPWpGaD
Dexfenfluramine—SLC6A4—SIDS Susceptibility Pathways—IL1B—chronic obstructive pulmonary disease	5.96e-05	0.00147	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Phase II conjugation—GSTP1—chronic obstructive pulmonary disease	5.91e-05	0.00146	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	5.89e-05	0.00145	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	5.84e-05	0.00144	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Biological oxidations—GCLC—chronic obstructive pulmonary disease	5.82e-05	0.00143	CbGpPWpGaD
Dexfenfluramine—HTR2B—GPCRs, Class A Rhodopsin-like—HTR2A—chronic obstructive pulmonary disease	5.78e-05	0.00142	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Biological oxidations—GCLC—chronic obstructive pulmonary disease	5.77e-05	0.00142	CbGpPWpGaD
Dexfenfluramine—CYP2E1—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	5.75e-05	0.00142	CbGpPWpGaD
Dexfenfluramine—CYP2E1—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	5.67e-05	0.0014	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	5.67e-05	0.0014	CbGpPWpGaD
Dexfenfluramine—HTR2B—Class A/1 (Rhodopsin-like receptors)—EDN1—chronic obstructive pulmonary disease	5.66e-05	0.00139	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Phase II conjugation—GSTM1—chronic obstructive pulmonary disease	5.43e-05	0.00134	CbGpPWpGaD
Dexfenfluramine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—chronic obstructive pulmonary disease	5.39e-05	0.00133	CbGpPWpGaD
Dexfenfluramine—HTR2B—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	5.39e-05	0.00133	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	5.32e-05	0.00131	CbGpPWpGaD
Dexfenfluramine—CYP2E1—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	5.28e-05	0.0013	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	5.25e-05	0.00129	CbGpPWpGaD
Dexfenfluramine—CYP2E1—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	5.21e-05	0.00128	CbGpPWpGaD
Dexfenfluramine—HTR2C—Class A/1 (Rhodopsin-like receptors)—ADRB2—chronic obstructive pulmonary disease	5.11e-05	0.00126	CbGpPWpGaD
Dexfenfluramine—CYP2A6—Metabolism—APIP—chronic obstructive pulmonary disease	5.1e-05	0.00126	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	5.08e-05	0.00125	CbGpPWpGaD
Dexfenfluramine—SLC6A4—SIDS Susceptibility Pathways—VEGFA—chronic obstructive pulmonary disease	5.05e-05	0.00124	CbGpPWpGaD
Dexfenfluramine—CYP2E1—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	5.01e-05	0.00123	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	4.99e-05	0.00123	CbGpPWpGaD
Dexfenfluramine—HTR2B—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	4.95e-05	0.00122	CbGpPWpGaD
Dexfenfluramine—CYP2E1—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	4.94e-05	0.00122	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Biological oxidations—GCLC—chronic obstructive pulmonary disease	4.93e-05	0.00122	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	4.89e-05	0.00121	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	4.89e-05	0.00121	CbGpPWpGaD
Dexfenfluramine—SLC6A4—NRF2 pathway—TGFB1—chronic obstructive pulmonary disease	4.88e-05	0.0012	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	4.85e-05	0.0012	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	4.82e-05	0.00119	CbGpPWpGaD
Dexfenfluramine—HTR2B—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	4.82e-05	0.00119	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—chronic obstructive pulmonary disease	4.79e-05	0.00118	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	4.78e-05	0.00118	CbGpPWpGaD
Dexfenfluramine—HTR2C—GPCRs, Class A Rhodopsin-like—HTR2A—chronic obstructive pulmonary disease	4.66e-05	0.00115	CbGpPWpGaD
Dexfenfluramine—HTR2C—Class A/1 (Rhodopsin-like receptors)—EDN1—chronic obstructive pulmonary disease	4.56e-05	0.00113	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	4.5e-05	0.00111	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	4.44e-05	0.00109	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	4.38e-05	0.00108	CbGpPWpGaD
Dexfenfluramine—HTR2C—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	4.35e-05	0.00107	CbGpPWpGaD
Dexfenfluramine—HTR2B—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	4.34e-05	0.00107	CbGpPWpGaD
Dexfenfluramine—SLC6A4—SIDS Susceptibility Pathways—TNF—chronic obstructive pulmonary disease	4.32e-05	0.00107	CbGpPWpGaD
Dexfenfluramine—HTR2B—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	4.31e-05	0.00106	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	4.1e-05	0.00101	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	4.08e-05	0.00101	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	4.08e-05	0.001	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—chronic obstructive pulmonary disease	4.05e-05	0.000999	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	4.05e-05	0.000997	CbGpPWpGaD
Dexfenfluramine—CYP2E1—Metabolism—APIP—chronic obstructive pulmonary disease	4.03e-05	0.000993	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	4.02e-05	0.000992	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	4.02e-05	0.000991	CbGpPWpGaD
Dexfenfluramine—HTR2C—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	3.99e-05	0.000984	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	3.99e-05	0.000983	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	3.95e-05	0.000973	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	3.94e-05	0.000972	CbGpPWpGaD
Dexfenfluramine—HTR2C—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	3.89e-05	0.000959	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	3.86e-05	0.000953	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	3.81e-05	0.00094	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	3.81e-05	0.00094	CbGpPWpGaD
Dexfenfluramine—HTR2B—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	3.77e-05	0.000929	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	3.75e-05	0.000924	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—chronic obstructive pulmonary disease	3.72e-05	0.000917	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	3.72e-05	0.000916	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	3.7e-05	0.000912	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	3.67e-05	0.000904	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—chronic obstructive pulmonary disease	3.65e-05	0.000899	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—chronic obstructive pulmonary disease	3.65e-05	0.000899	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	3.55e-05	0.000876	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	3.52e-05	0.000869	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	3.51e-05	0.000864	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	3.51e-05	0.000864	CbGpPWpGaD
Dexfenfluramine—HTR2C—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	3.5e-05	0.000864	CbGpPWpGaD
Dexfenfluramine—SLC6A4—SIDS Susceptibility Pathways—IL6—chronic obstructive pulmonary disease	3.49e-05	0.00086	CbGpPWpGaD
Dexfenfluramine—HTR2C—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	3.48e-05	0.000857	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	3.48e-05	0.000857	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Aryl Hydrocarbon Receptor—TNF—chronic obstructive pulmonary disease	3.47e-05	0.000856	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—chronic obstructive pulmonary disease	3.47e-05	0.000856	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	3.46e-05	0.000852	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	3.41e-05	0.00084	CbGpPWpGaD
Dexfenfluramine—CYP2A6—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	3.38e-05	0.000833	CbGpPWpGaD
Dexfenfluramine—CYP2A6—Metabolism—GC—chronic obstructive pulmonary disease	3.29e-05	0.00081	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	3.18e-05	0.000784	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	3.18e-05	0.000783	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	3.13e-05	0.000772	CbGpPWpGaD
Dexfenfluramine—SLC6A4—Circadian rythm related genes—TP53—chronic obstructive pulmonary disease	3.11e-05	0.000767	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—APIP—chronic obstructive pulmonary disease	3.11e-05	0.000766	CbGpPWpGaD
Dexfenfluramine—CYP2A6—NRF2 pathway—TGFB1—chronic obstructive pulmonary disease	3.11e-05	0.000766	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	3.08e-05	0.000759	CbGpPWpGaD
Dexfenfluramine—HTR2B—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	3.06e-05	0.000754	CbGpPWpGaD
Dexfenfluramine—CYP2A6—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	3.05e-05	0.000753	CbGpPWpGaD
Dexfenfluramine—HTR2C—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	3.04e-05	0.00075	CbGpPWpGaD
Dexfenfluramine—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—chronic obstructive pulmonary disease	3.02e-05	0.000744	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	3.01e-05	0.000742	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	2.97e-05	0.000732	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	2.89e-05	0.000713	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—APIP—chronic obstructive pulmonary disease	2.86e-05	0.000705	CbGpPWpGaD
Dexfenfluramine—SLC6A4—Circadian rythm related genes—IL6—chronic obstructive pulmonary disease	2.85e-05	0.000702	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—APIP—chronic obstructive pulmonary disease	2.83e-05	0.000699	CbGpPWpGaD
Dexfenfluramine—HTR2B—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	2.72e-05	0.000672	CbGpPWpGaD
Dexfenfluramine—CYP2E1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.67e-05	0.000658	CbGpPWpGaD
Dexfenfluramine—CYP2E1—Metabolism—GC—chronic obstructive pulmonary disease	2.6e-05	0.00064	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	2.47e-05	0.00061	CbGpPWpGaD
Dexfenfluramine—HTR2C—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	2.47e-05	0.000608	CbGpPWpGaD
Dexfenfluramine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—chronic obstructive pulmonary disease	2.43e-05	0.0006	CbGpPWpGaD
Dexfenfluramine—HTR2B—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	2.43e-05	0.0006	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—APIP—chronic obstructive pulmonary disease	2.42e-05	0.000597	CbGpPWpGaD
Dexfenfluramine—CYP2E1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.41e-05	0.000595	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	2.33e-05	0.000575	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	2.33e-05	0.000574	CbGpPWpGaD
Dexfenfluramine—HTR2B—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	2.33e-05	0.000574	CbGpPWpGaD
Dexfenfluramine—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—chronic obstructive pulmonary disease	2.32e-05	0.000572	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	2.22e-05	0.000547	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	2.21e-05	0.000545	CbGpPWpGaD
Dexfenfluramine—HTR2C—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	2.2e-05	0.000542	CbGpPWpGaD
Dexfenfluramine—HTR2B—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	2.13e-05	0.000525	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.06e-05	0.000508	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	2.04e-05	0.000504	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	2.02e-05	0.000498	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—GC—chronic obstructive pulmonary disease	2e-05	0.000494	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	2e-05	0.000492	CbGpPWpGaD
Dexfenfluramine—HTR2C—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	1.96e-05	0.000484	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	1.93e-05	0.000477	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.89e-05	0.000467	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	1.88e-05	0.000463	CbGpPWpGaD
Dexfenfluramine—HTR2C—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	1.88e-05	0.000463	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.88e-05	0.000463	CbGpPWpGaD
Dexfenfluramine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—chronic obstructive pulmonary disease	1.87e-05	0.000461	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.86e-05	0.000459	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	1.86e-05	0.000459	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—GC—chronic obstructive pulmonary disease	1.84e-05	0.000454	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—GC—chronic obstructive pulmonary disease	1.83e-05	0.00045	CbGpPWpGaD
Dexfenfluramine—CYP2A6—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.8e-05	0.000443	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	1.78e-05	0.00044	CbGpPWpGaD
Dexfenfluramine—CYP2A6—Metabolism—GCLC—chronic obstructive pulmonary disease	1.77e-05	0.000437	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	1.73e-05	0.000426	CbGpPWpGaD
Dexfenfluramine—HTR2C—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	1.72e-05	0.000424	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.71e-05	0.000422	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	1.7e-05	0.00042	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.7e-05	0.000419	CbGpPWpGaD
Dexfenfluramine—CYP2A6—Metabolism—CTGF—chronic obstructive pulmonary disease	1.62e-05	0.000399	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.6e-05	0.000396	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—KL—chronic obstructive pulmonary disease	1.58e-05	0.00039	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—GC—chronic obstructive pulmonary disease	1.56e-05	0.000385	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	1.56e-05	0.000385	CbGpPWpGaD
Dexfenfluramine—CYP2A6—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.49e-05	0.000368	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	1.48e-05	0.000366	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	1.46e-05	0.00036	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.45e-05	0.000358	CbGpPWpGaD
Dexfenfluramine—CYP2E1—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.42e-05	0.00035	CbGpPWpGaD
Dexfenfluramine—CYP2E1—Metabolism—GCLC—chronic obstructive pulmonary disease	1.4e-05	0.000346	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	1.37e-05	0.000339	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	1.35e-05	0.000334	CbGpPWpGaD
Dexfenfluramine—HTR2B—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	1.32e-05	0.000324	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	1.31e-05	0.000322	CbGpPWpGaD
Dexfenfluramine—CYP2E1—Metabolism—CTGF—chronic obstructive pulmonary disease	1.28e-05	0.000315	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—KL—chronic obstructive pulmonary disease	1.28e-05	0.000315	CbGpPWpGaD
Dexfenfluramine—CYP2A6—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.24e-05	0.000307	CbGpPWpGaD
Dexfenfluramine—CYP2A6—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.23e-05	0.000303	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	1.19e-05	0.000295	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	1.19e-05	0.000293	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	1.18e-05	0.000291	CbGpPWpGaD
Dexfenfluramine—CYP2E1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.18e-05	0.000291	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	1.16e-05	0.000285	CbGpPWpGaD
Dexfenfluramine—CYP2A6—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.14e-05	0.000282	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	1.14e-05	0.000282	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.09e-05	0.00027	CbGpPWpGaD
Dexfenfluramine—CYP2A6—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.08e-05	0.000267	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—GCLC—chronic obstructive pulmonary disease	1.08e-05	0.000267	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—LEP—chronic obstructive pulmonary disease	1.06e-05	0.000262	CbGpPWpGaD
Dexfenfluramine—HTR2C—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	1.06e-05	0.000262	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	1.05e-05	0.00026	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	1.01e-05	0.000249	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.01e-05	0.000248	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—GSTT1—chronic obstructive pulmonary disease	9.98e-06	0.000246	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—GCLC—chronic obstructive pulmonary disease	9.95e-06	0.000245	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—CTGF—chronic obstructive pulmonary disease	9.87e-06	0.000243	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—GCLC—chronic obstructive pulmonary disease	9.86e-06	0.000243	CbGpPWpGaD
Dexfenfluramine—CYP2E1—Metabolism—GSTP1—chronic obstructive pulmonary disease	9.83e-06	0.000242	CbGpPWpGaD
Dexfenfluramine—CYP2E1—Metabolism—HMOX1—chronic obstructive pulmonary disease	9.7e-06	0.000239	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	9.64e-06	0.000238	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	9.58e-06	0.000236	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	9.22e-06	0.000227	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	9.2e-06	0.000227	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—CYP1A2—chronic obstructive pulmonary disease	9.1e-06	0.000224	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—CTGF—chronic obstructive pulmonary disease	9.08e-06	0.000224	CbGpPWpGaD
Dexfenfluramine—CYP2E1—Metabolism—GSTM1—chronic obstructive pulmonary disease	9.04e-06	0.000223	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—CTGF—chronic obstructive pulmonary disease	9e-06	0.000222	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	8.73e-06	0.000215	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—LEP—chronic obstructive pulmonary disease	8.57e-06	0.000211	CbGpPWpGaD
Dexfenfluramine—CYP2E1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	8.57e-06	0.000211	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—GSTT1—chronic obstructive pulmonary disease	8.53e-06	0.00021	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—GCLC—chronic obstructive pulmonary disease	8.43e-06	0.000208	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—CYP1A2—chronic obstructive pulmonary disease	8.37e-06	0.000206	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	8.33e-06	0.000205	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—CYP1A2—chronic obstructive pulmonary disease	8.29e-06	0.000204	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	7.96e-06	0.000196	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	7.86e-06	0.000194	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—CTGF—chronic obstructive pulmonary disease	7.69e-06	0.00019	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—GSTP1—chronic obstructive pulmonary disease	7.59e-06	0.000187	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—HMOX1—chronic obstructive pulmonary disease	7.48e-06	0.000184	CbGpPWpGaD
Dexfenfluramine—CYP2A6—Metabolism—ALB—chronic obstructive pulmonary disease	7.37e-06	0.000182	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	7.06e-06	0.000174	CbGpPWpGaD
Dexfenfluramine—CYP2A6—Metabolism—NOS3—chronic obstructive pulmonary disease	7.05e-06	0.000174	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	7.05e-06	0.000174	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—GSTP1—chronic obstructive pulmonary disease	6.98e-06	0.000172	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—GSTM1—chronic obstructive pulmonary disease	6.97e-06	0.000172	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—GSTP1—chronic obstructive pulmonary disease	6.92e-06	0.000171	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—HMOX1—chronic obstructive pulmonary disease	6.88e-06	0.00017	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—HMOX1—chronic obstructive pulmonary disease	6.82e-06	0.000168	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	6.72e-06	0.000166	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	6.71e-06	0.000165	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—CYP1A1—chronic obstructive pulmonary disease	6.61e-06	0.000163	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	6.42e-06	0.000158	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—GSTM1—chronic obstructive pulmonary disease	6.41e-06	0.000158	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	6.38e-06	0.000157	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—GSTM1—chronic obstructive pulmonary disease	6.36e-06	0.000157	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—CYP1A1—chronic obstructive pulmonary disease	6.08e-06	0.00015	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—CYP1A1—chronic obstructive pulmonary disease	6.03e-06	0.000149	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—GSTP1—chronic obstructive pulmonary disease	5.91e-06	0.000146	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—HMOX1—chronic obstructive pulmonary disease	5.83e-06	0.000144	CbGpPWpGaD
Dexfenfluramine—CYP2E1—Metabolism—ALB—chronic obstructive pulmonary disease	5.82e-06	0.000144	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	5.73e-06	0.000141	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	5.69e-06	0.00014	CbGpPWpGaD
Dexfenfluramine—CYP2E1—Metabolism—NOS3—chronic obstructive pulmonary disease	5.57e-06	0.000137	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—GSTM1—chronic obstructive pulmonary disease	5.43e-06	0.000134	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	5.42e-06	0.000133	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	5.26e-06	0.00013	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	5.16e-06	0.000127	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	5.15e-06	0.000127	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	5.15e-06	0.000127	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	4.63e-06	0.000114	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—ALB—chronic obstructive pulmonary disease	4.49e-06	0.000111	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—TP53—chronic obstructive pulmonary disease	4.33e-06	0.000107	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—NOS3—chronic obstructive pulmonary disease	4.3e-06	0.000106	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	4.25e-06	0.000105	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	4.16e-06	0.000103	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—ALB—chronic obstructive pulmonary disease	4.13e-06	0.000102	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—ALB—chronic obstructive pulmonary disease	4.1e-06	0.000101	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—IL6—chronic obstructive pulmonary disease	3.97e-06	9.77e-05	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—NOS3—chronic obstructive pulmonary disease	3.95e-06	9.74e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—NOS3—chronic obstructive pulmonary disease	3.92e-06	9.66e-05	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—ALB—chronic obstructive pulmonary disease	3.5e-06	8.63e-05	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—TP53—chronic obstructive pulmonary disease	3.49e-06	8.62e-05	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—NOS3—chronic obstructive pulmonary disease	3.35e-06	8.25e-05	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—IL6—chronic obstructive pulmonary disease	3.2e-06	7.89e-05	CbGpPWpGaD
